Focused Categories for Clearer Understanding

Pharmacology

Direct Thrombin Inhibitors, DTI pharmacology, doac, dabigatran, Bivalirudin, Anticoagulants, anticoagulation, Pradaxa, Argatroban, Hirudin, drbusti

Pharmacology

heparin, unfractionated heparin, UFH,low molecular weight heparin, LMWH, enoxaparin, lovenox,dalteparin, fondaparinex, dabigatran, anticoagulants, anticoagulation, heparin mechanism of action, heparin pharmacology, heparin vs enoxaparin, heparin induced thrombocytopenia, HIT, NCLEX pharmacology, dr busti

Pharmacology

warfarin, coumadin, VKA, Warfarin Pharmacology, Vitamin K Antagonist, Warfarin Dosing, Warfarin Interactions, dr busti

Pharmacology

Crush P2Y12 (ADP) inhibitors fast—clopidogrel, prasugrel, ticagrelor, and cangrelor explained with real-world, exam-ready clarity.

Pharmacology

gpiibiiiainhibitors, tirofiban, antiplateletpharmacology, eptifibatide, drbusti, glycoprotein IIb/IIIa, GP IIb IIIa inhibitor, abciximab, eptifibatide, tirofiban, Integrilin, Aggrastat, intravenous antiplatelet, antiplatelet drugs, antiplatelet pharmacology, platelet aggregation inhibitor, PCI pharmacology, acute coronary syndrome, STEMI NSTEMI, stent thrombosis, cardiology pharmacology, NCLEX pharmacology, Dr Busti

Anatomy & Physiology

Platelet Aggregation, Thrombosis, Hemostasis, Platelet Physiology, thrombus, thrombus formation, venous thrombus, arterial thrombus, drbusti

Anatomy & Physiology

Coagulation Cascade, Hemostasis, Clotting Factors, Thrombin, Fibrin, thrombosis, Thrombus formation, Blood Clotting Cascade, Physiology Made Easy, dr busti

Pharmacology

aspirin, asa, salicylic acid, acetylsalicylic acid, antiplatelet, antiplatelet drugs, COX-1 inhibition, thromboxane A2, TXA2, cardiovascular pharmacology, MI prevention, stroke prevention, secondary prevention, salicylates, Dr Busti

Pharmacology

lipid-lowering drugs, LDL drugs pharmacology, Bempedoic Acid, nexletol, statin intolerance, busti

Pharmacology

omega 3 fatty acids, omega-3 fatty acids, fish oil, icosapent ethyl, vascepa, epa, dha, epa vs dha, pufa, polyunsaturated fatty acids, hypertriglyceridemia, triglyceride lowering, severe hypertriglyceridemia, lipid lowering drugs, lipid management, dr busti

Pharmacology

statins, statins pharmacology, HMG CoA reductase inhibitors, LDL lowering, lipid lowering drugs, hyperlipidemia, atorvastatin, rosuvastatin, simvastatin, pravastatin, high intensity statin, ASCVD prevention, cardiovascular risk reduction, statin side effects, statin myopathy, rhabdomyolysis, NCLEX pharmacology, drbusti

Pharmacology

meglitinides, repaglinide, nateglinide, type 2 diabetes, diabetes pharmacology, insulin secretagogues, repaglinide pharmacology, nateglinide pharmacology, busti, dr busti, Anthony Busti